Assessing the impact of imperfect adherence to artemether-lumefantrine on malaria treatment outcomes using within-host modelling

Artemether lumefantrine is widely used for the treatment of uncomplicated malaria. The impact of imperfect patient adherence to the six-dose regimen is hard to assess. Using adherence data for unsupervised patients, the authors model how suboptimal adherence affects treatment outcomes.

Guardado en:
Detalles Bibliográficos
Autores principales: Joseph D. Challenger, Katia Bruxvoort, Azra C. Ghani, Lucy C. Okell
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/be1a2b6957f54156a4adac50845795aa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:be1a2b6957f54156a4adac50845795aa
record_format dspace
spelling oai:doaj.org-article:be1a2b6957f54156a4adac50845795aa2021-12-02T17:01:18ZAssessing the impact of imperfect adherence to artemether-lumefantrine on malaria treatment outcomes using within-host modelling10.1038/s41467-017-01352-32041-1723https://doaj.org/article/be1a2b6957f54156a4adac50845795aa2017-11-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-01352-3https://doaj.org/toc/2041-1723Artemether lumefantrine is widely used for the treatment of uncomplicated malaria. The impact of imperfect patient adherence to the six-dose regimen is hard to assess. Using adherence data for unsupervised patients, the authors model how suboptimal adherence affects treatment outcomes.Joseph D. ChallengerKatia BruxvoortAzra C. GhaniLucy C. OkellNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-9 (2017)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Joseph D. Challenger
Katia Bruxvoort
Azra C. Ghani
Lucy C. Okell
Assessing the impact of imperfect adherence to artemether-lumefantrine on malaria treatment outcomes using within-host modelling
description Artemether lumefantrine is widely used for the treatment of uncomplicated malaria. The impact of imperfect patient adherence to the six-dose regimen is hard to assess. Using adherence data for unsupervised patients, the authors model how suboptimal adherence affects treatment outcomes.
format article
author Joseph D. Challenger
Katia Bruxvoort
Azra C. Ghani
Lucy C. Okell
author_facet Joseph D. Challenger
Katia Bruxvoort
Azra C. Ghani
Lucy C. Okell
author_sort Joseph D. Challenger
title Assessing the impact of imperfect adherence to artemether-lumefantrine on malaria treatment outcomes using within-host modelling
title_short Assessing the impact of imperfect adherence to artemether-lumefantrine on malaria treatment outcomes using within-host modelling
title_full Assessing the impact of imperfect adherence to artemether-lumefantrine on malaria treatment outcomes using within-host modelling
title_fullStr Assessing the impact of imperfect adherence to artemether-lumefantrine on malaria treatment outcomes using within-host modelling
title_full_unstemmed Assessing the impact of imperfect adherence to artemether-lumefantrine on malaria treatment outcomes using within-host modelling
title_sort assessing the impact of imperfect adherence to artemether-lumefantrine on malaria treatment outcomes using within-host modelling
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/be1a2b6957f54156a4adac50845795aa
work_keys_str_mv AT josephdchallenger assessingtheimpactofimperfectadherencetoartemetherlumefantrineonmalariatreatmentoutcomesusingwithinhostmodelling
AT katiabruxvoort assessingtheimpactofimperfectadherencetoartemetherlumefantrineonmalariatreatmentoutcomesusingwithinhostmodelling
AT azracghani assessingtheimpactofimperfectadherencetoartemetherlumefantrineonmalariatreatmentoutcomesusingwithinhostmodelling
AT lucycokell assessingtheimpactofimperfectadherencetoartemetherlumefantrineonmalariatreatmentoutcomesusingwithinhostmodelling
_version_ 1718382172045312000